Sesquiterpenoids from myrrh inhibit androgen receptor expression and function in human prostate cancer cells
Authors:
- 4 March 2011
- journal article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 32 (3) , 338-344
Abstract
Aim: Methods: Results: Conclusion:Keywords
This publication has 22 references indexed in Scilit:
- Oncogenic activation of androgen receptorUrologic Oncology: Seminars and Original Investigations, 2009
- Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cellsCarcinogenesis, 2005
- Prostate specific antigen gene regulation by androgen receptorJournal of Cellular Biochemistry, 2004
- Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate CancerJournal of Biological Chemistry, 2004
- Androgen receptor: A key molecule in the progression of prostate cancer to hormone independenceJournal of Cellular Biochemistry, 2003
- Androgen receptor gene amplification and protein expression in hormone refractory prostate cancerBritish Journal of Cancer, 2003
- Reducing the Agonist Activity of Antiandrogens by a Dominant-negative Androgen Receptor Coregulator ARA70 in Prostate Cancer CellsJournal of Biological Chemistry, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Furanosesquiterpenoids of Commiphora myrrhaJournal of Natural Products, 2001
- Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor SuperfamilyScience, 1995